Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
Saif ur Rahman, Trainee Medical laboratory technologist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on LinkedIn:
”K2 EDTA vs K3 EDTA – Key Differences Explained
Choosing the correct EDTA tube is critical for accurate hematology results.
Here’s a simple breakdown every lab professional should know
1. Chemical Composition
K2 EDTA → Dipotassium EDTA
K3 EDTA → Tripotassium EDTA
Both act as anticoagulants by binding calcium, preventing clot formation.
2. Additive Form
K2 EDTA → Spray-dried powder
K3 EDTA → Liquid additive
Liquid K3 EDTA can slightly dilute the blood sample.
3. Effect on Blood Cells
K2 EDTA
• Better preservation of cell morphology
• Accurate RBC, WBC and platelet counts
K3 EDTA
• May cause cell shrinkage
• Can affect MCV and hematocrit values
4. Dilution Effect
K2 EDTA → Minimal dilution
K3 EDTA → Slight dilution (due to liquid form)
5. Preferred Laboratory Use
K2 EDTA Gold standard for Routine CBC and Hematology
K3 EDTA
Used for general CBC / rapid testing
Summary
K2 EDTA → Better cell preservation and reliable CBC results
K3 EDTA → Faster anticoagulation but minor dilution effects
Most modern laboratories prefer K2 EDTA for routine hematology.
Lab Tip
Correct tube selection equals accurate results plus better patient care”
Stay updated with Hemostasis Today.
-
Mar 16, 2026, 17:01Jeff Sternlicht: The Most Powerful Time to Lower Cholesterol Is Before Anyone Thinks You Need It
-
Mar 16, 2026, 16:14Siobhan Calafiore: Clinical Advantages of Apixaban Over Rivaroxaban in Reducing Bleeding Risk
-
Mar 16, 2026, 16:12Nuha El Sayed: Focused Summary of the 2026 ACC/AHA Guideline on Management of Dyslipidemia in Diabetes
-
Mar 16, 2026, 16:08Deepak Sudheendra: When a Vascular Looking Skin Pattern Isn’t Vascular
-
Mar 16, 2026, 16:06Surendra Karki։ Examining Blood Type and Coronary Heart Disease Risk in Australian Donors
-
Mar 16, 2026, 15:58Alan Nurden: Genome-Wide Analyses Unravel the Genetic Architecture of Coagulation and Fibrinolysis
-
Mar 16, 2026, 15:56Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
-
Mar 16, 2026, 15:53Suvro Sankha Datta: Reporting Auto-Anti-Jk Antibodies in Children with Hematological Disorders
-
Mar 16, 2026, 15:44Francis Kynaston-Pearson: Why Randomised Controlled Trials Are the Gold Standard in Clinical Research